Table 3. Crude multiple logistic regression for risk factors associated with progression towards severe disease or death at day 14.
| Population: patients with baseline suPAR ≥ 6ng/mL who fulfilled the prescriptive criteria for anakinra (n = 105) | ||||||
|---|---|---|---|---|---|---|
| Variable | Univariable | Multivariable | ||||
| OR1 | 95% CI1 | p-value | OR1 | 95% CI1 | p-value | |
| Age (years) | 1.07 | 1.03, 1.13 | 0.005 | 1.09 | 1.03, 1.15 | 0.004 |
| Anakinra | 0.31 | 0.08, 1.01 | 0.064 | 0.32 | 0.08, 1.12 | 0.087 |
| PaO2/FiO2 ratio | 1.00 | 0.99, 1.01 | 0.371 | 0.99 | 0.98, 1.00 | 0.154 |
OR: Odds Ratio; CI: Confidence Interval.
Severe disease is defined according to the WHO Clinical Progression Scale (WHO-CPS score 6–10).